Hematologic Malignancy
Primary Cutaneous Lymphoma
CI-CAN-00003736Explore in graph →
Hematologic67 active trials10 approved drugs
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00003736Explore in graph →
Clinical trials
353 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (77)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00496743 | Study of Low-Dose Total Skin Electron Beam Therapy in Mycosis Fungoides | terminated | N/A | 10 | Bispebjerg HospitalOTHER | 0 | Jul 4, 2007 | clinicaltrials |
| NCT00157274 | Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome | unknown | Phase 2 | 20 | Latin American Cooperative Onco-Haematology Group - PeruOTHER | 1 | Apr 3, 2007 | clinicaltrials |
| NCT00306969 |
| Study of Oral Bexarotene in Combination With Photopheresis for Treatment of Cutaneous T-Cell Lymphoma |
| completed |
| Phase 1 / Phase 2 |
| 18 |
| Boston UniversityOTHER |
| 1 |
| Mar 27, 2006 |
| clinicaltrials |
Data updated 22 days agoSource updated Jul 4, 2007source: clinicaltrials